Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signaling

Weissmueller, Susann, Manchado, Eusebio, Saborowski, Michael, Morris, John P., Wagenblast, Elvin, Davis, Carrie A., Moon, Sung-Hwan, Pfister, Neil T. +10 more·2014·Cell

DOI 10.1016/j.cell.2014.01.066

Cited by (470)

Items 201–300 of 470

Mutant p53 – Heat Shock Response Oncogenic Cooperation: A New Mechanism of Cancer Cell Survival
Evguenia M. Alexandrova, Natalia D. Marchenko · 2015 · Frontiers in Endocrinology
Cotargeting of MEK and PDGFR/STAT3 Pathways to Treat Pancreatic Ductal Adenocarcinoma
Nisebita Sahu, Emily Chan, Felix Chu, Thinh Q. Pham, Hartmut Koeppen, William F. Forrest, Mark A. Merchant, Jeff Settleman · 2017 · Molecular Cancer Therapeutics
Tumor-Infiltrating Immune Cell Signature Predicts the Prognosis and Chemosensitivity of Patients With Pancreatic Ductal Adenocarcinoma
Yuzhen Gao, Shipeng Chen, Somayeh Vafaei, Xiaoli Zhong · 2020 · Frontiers in Oncology
Glutathionylation-dependent proteasomal degradation of wide-spectrum mutant p53 proteins by engineered zeolitic imidazolate framework-8
Yunjiao Zhang, Xiaowan Huang, Liansheng Wang, Cong Cao, Hao Zhang, Pengfei Wei, He Ding, Yang Song, Ziying Chen, Jieying Qian et al. · 2021 · Biomaterials
miR-17-5p promotes the invasion and migration of colorectal cancer by regulating HSPB2
Weifang Yu, Jia Wang, Chao Li, Mingda Xuan, Shuangshuang Han, Yingfu Zhang, Pengfei Liu, Zengren Zhao · 2022 · Journal of Cancer
p53 and its mutants on the slippery road from stemness to carcinogenesis
Alina Molchadsky, Varda Rotter · 2017 · Carcinogenesis
Analysis of clinical factors and PDGFR-β in predicting prognosis of patients with clival chordoma
Yixuan Zhai, Jiwei Bai, Shuai Wang, Hua Gao, Mingxuan Li, Chuzhong Li, Songbai Gui, Yazhuo Zhang · 2018 · Journal of neurosurgery
Mutant p53 and chromatin regulation
Carol L. Prives, Scott W. Lowe · 2015 · Nature
Molecular profiling and computational network analysis of TAZ-mediated mammary tumorigenesis identifies actionable therapeutic targets
Costa G. Frangou, Yingwei Li, He Shen, Nuo Yang, Kayla E. Wilson, Maxime Blijlevens, Jin Guo, Norma J. Nowak, Jianmin Zhang · 2014 · Oncotarget
Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients with preoperative serum CA19-9 ≥ 1,000 U/mL
Jin-Feng Xiang, Wen-Quan Wang, Liang Liu, Huaxiang Xu, Chuntao Wu, Jingxuan Yang, Zi-Hao Qi, Ya-Qi Wang, Jin Xu, Chen Liu et al. · 2016 · Scientific Reports · Retracted
Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer
Sharon Wang, Jeff C. Liu, Danbi Kim, Alessandro Datti, Eldad Zacksenhaus · 2016 · Breast Cancer Research
TP53/miR-34a-associated signaling targets SERPINE1 expression in human pancreatic cancer
Shaw M. Akula, Peter P. Ruvolo, James Andrew McCubrey · 2020 · Aging
Impact of p53 and PDGFR‐β Expression on Metastasis and Prognosis of Patients with Pancreatic Cancer
Hiroshi Kurahara, Kosei Maemura, Yuko Mataki, Masahiko Sakoda, Hiroyuki Shinchi, Shoji Natsugoe · 2016 · World Journal of Surgery
Unraveling cancer lineage drivers in squamous cell carcinomas
Yinglu Guan, Guan Wang, Danielle Fails, Priyadharsini Nagarajan, Yejing Ge · 2019 · Pharmacology & Therapeutics
Complexes formed by mutant p53 and their roles in breast cancer
Arianna Bellazzo, Daria Sicari, Elena Valentino, Giannino Del Sal, Licio Collavin · 2018 · Breast Cancer Targets and Therapy
Mixed Lineage Kinase 3 phosphorylates prolyl-isomerase PIN1 and potentiates GLI1 signaling in pancreatic cancer development
Navin Viswakarma, Gautam V. Sondarva, Daniel R. Principe, Rakesh Sathish Nair, Sandeep Kumar, Sunil Kumar Singh, Subhasis Das, Subhash C. Sinha, Paul J. Grippo, Sam Grimaldo et al. · 2021 · Cancer Letters
Different impacts of TP53 mutations on cell cycle-related gene expression among cancer types
Keiju Sasaki, Shinʼ ichi Takahashi, Kota Ouchi, Yasufumi Otsuki, Shonosuke Wakayama, Chikashi Ishioka · 2023 · Scientific Reports
Emerging role of pancreatic stellate cell-derived extracellular vesicles in pancreatic cancer
Rohit Sarkar, Zhihong Xu, Chamini Jayamali Perera, Minoti Vivek Apte · 2023 · Seminars in Cancer Biology
A Five-Gene Signature Predicts Prognosis in Patients with Kidney Renal Clear Cell Carcinoma
Yueping Zhan, Wenna Guo, Ying Zhang, Qiang Wang, Xin‐Jian Xu, Liucun Zhu · 2015 · Computational and Mathematical Methods in Medicine
IRTKS is correlated with progression and survival time of patients with gastric cancer
Liyu Huang, Xuefei Wang, Xiaofang Cui, Li He, Junjie Zhao, Chong-Chao Wu, Lingqiang Min, Zhicheng Zhou, Lixin Wan, Yuping Wang et al. · 2017 · Gut
Impact of RNA-Guided Technologies for Target Identification and Deconvolution
Myles Fennell, Qing Xiang, Alexia Hwang, Chong Chen, Chun‐Hao Huang, Chi-Chao Chen, Raphael A. Pelossof, Ralph J. Garippa · 2014 · SLAS DISCOVERY
p53: Multiple Facets of a Rubik's Cube
Yun Zhang, Guillermina Lozano · 2016 · Annual Review of Cancer Biology
Salvation of the fallen angel: Reactivating mutant p53
Li Yang, Zhuoyi Wang, Yuchen Chen, Robert B. Petersen, Ling Zheng, Kun Huang · 2019 · British Journal of Pharmacology
Efficient Propagation of Circulating Tumor Cells: A First Step for Probing Tumor Metastasis
Jerry Xiao, Joseph R. McGill, Kelly Patrick Stanton, Joshua D. Kassner, Sujata Choudhury, Richard Schlegel, Zuben E. Sauna, Paula Raffin Pohlmann, Seema Agarwal · 2020 · Cancers
MiR-142-3p is downregulated in aggressive p53 mutant mouse models of pancreatic ductal adenocarcinoma by hypermethylation of its locus
Jack D. Godfrey, Jennifer P. Morton, Ania Wilczynska, Owen James Sansom, Martin Bushell · 2018 · Cell Death and Disease
Pancreatic Cancer Gene Therapy Delivered by Nanoparticles
Trevin Robert Kurtanich, Nicole Roos, Guanmeng Wang, Jesse Yang, Alan Wang, Eun Ji Chung · 2018 · SLAS TECHNOLOGY
Identification of genomic alterations and associated transcriptomic profiling reveal the prognostic significance of MMP14 and PKM2 in patients with pancreatic cancer
Haiwei Wang, Xinrui Wang, Liangpu Xu, Yingying Lin, Ji Zhang, Hua Cao · 2020 · Aging
Computational and experimental characterization of the novel ECM glycoprotein SNED1 and prediction of its interactome
Sylvain D. Vallet, Martin N. Davis, Anna Barqué, Ali H. Thahab, Sylvie Ricard‐Blum, Alexandra Naba · 2021 · Biochemical Journal
NUAK2 and RCan2 participate in the p53 mutant pro-tumorigenic network
Eleonora Mammarella, Carlotta Zampieri, Emanuele Panatta, Gerry Melino, Ivano Amelio · 2021 · Biology Direct
Transforming growth factor-β in pancreatic diseases: Mechanisms and therapeutic potential
Qi Zhou, Shilin Xia, Fangyue Guo, Fenglin Hu, Zhizhou Wang, Yujia Ni, Tianfu Wei, Hong Xiang, Dong Shang · 2019 · Pharmacological Research
A Pipeline for Drug Target Identification and Validation
Eusebio Manchado, Chun‐Hao Huang, Nilgun Tasdemir, Darjus Felix Tschaharganeh, John Erby Wilkinson, Scott W. Lowe · 2016 · Cold Spring Harbor Symposia on Quantitative Biology
Development of a Method to Implement Whole-Genome Bisulfite Sequencing of cfDNA from Cancer Patients and a Mouse Tumor Model
Elaine C. Maggi, Silvia Gravina, Haiying Cheng, Bilal Piperdi, Ziqiang Yuan, Xiao Dong, Steven K. Libutti, Jan Vijg, Cristina Montagna · 2018 · Frontiers in Genetics
Mouse-Derived Allografts: A Complementary Model to the KPC Mice on Researching Pancreatic Cancer In Vivo
Jie Li, Weikun Qian, Tao Qin, Ying Xiao, Liang Cheng, Junyu Cao, Xin Chen, Qingyong Ma, Zheng Wu · 2019 · Computational and Structural Biotechnology Journal
High expression of AMAP1, an ARF6 effector, is associated with elevated levels of PD-L1 and fibrosis of pancreatic cancer
Akio Tsutaho, Ari Hashimoto, Shigeru Hashimoto, Soichiro Hata, Shion Kachi, Satoshi Hirano, Hisataka Sabe · 2020 · Cell Communication and Signaling
Knockout of the gene encoding the extracellular matrix protein SNED1 results in early neonatal lethality and craniofacial malformations
Anna Barqué, Kyleen Jan, Emanuel De La Fuente, Christina L. Nicholas, Richard O. Hynes, Alexandra Naba · 2020 · Developmental Dynamics
Deregulation of Transcription Factor Networks Driving Cell Plasticity and Metastasis in Pancreatic Cancer
Ruthger van Roey, Thomas Brabletz, Marc P. Stemmler, Isabell Armstark · 2021 · Frontiers in Cell and Developmental Biology
MNX1-HNF1B Axis Is Indispensable for Intraductal Papillary Mucinous Neoplasm Lineages
Hiroyuki Kato, Keisuke Tateishi, Hiroaki Fujiwara, Takuma Nakatsuka, Keisuke Yamamoto, Yotaro Kudo, Yoku Hayakawa, Hayato Nakagawa, Yasuo Tanaka, Hideaki Ijichi et al. · 2021 · Gastroenterology
Rewired m6A epitranscriptomic networks link mutant p53 to neoplastic transformation
An Xu, Mo Liu, Mo-Fan Huang, Yang Zhang, Ruifeng Hu, Julian A. Gingold, Ying Liu, Dandan Zhu, Chian‐Shiu Chien, Wei‐Chen Wang et al. · 2023 · Nature Communications
NF-YC in glioma cell proliferation and tumor growth and its role as an independent predictor of patient survival
Hua Lei Cui, Mingkun Zhang, Yanxia Wang, Yong Wang · 2016 · Neuroscience Letters
A Driver Never Works Alone—Interplay Networks of Mutant p53, MYC, RAS, and Other Universal Oncogenic Drivers in Human Cancer
Maria Grzes, Magdalena Oroń, Zuzanna Staszczak, Akanksha Jaiswar, Magdalena Nowak-Niezgoda, Dawid Walerych · 2020 · Cancers
Dual Role of p73 in Cancer Microenvironment and DNA Damage Response
Julian Markovich Rozenberg, Svetlana D. Zvereva, Alexandra A. Dalina, Igor Blatov, Ilya V. Zubarev, Daniil V. Luppov, Alexander Bessmertnyi, Alexander O. Romanishin, Lamak Alsoulaiman, Vadim Vladimirovich Kumeiko et al. · 2021 · Cells
Histone deacetylases: A novel class of therapeutic targets for pancreatic cancer
Xue-Song Xiang, Pengcheng Li, Wenquan Wang, Liang Liu · 2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Transcriptome Analysis of Goat Mammary Gland Tissue Reveals the Adaptive Strategies and Molecular Mechanisms of Lactation and Involution
Rong Xuan, Jianmin Wang, Xiaodong Zhao, Qing Li, Yanyan Wang, Shanfeng Du, Qingling Duan, Yanfei Guo, Zhibin Ji, Tianle Chao · 2022 · International Journal of Molecular Sciences
Overcoming therapeutic resistance in pancreatic cancer: Emerging opportunities by targeting BRCAs and p53
Juliana Calheiros, Vincenzo Corbo, Lucı́lia Saraiva · 2023 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Genetic variants in the platelet‐derived growth factor subunit B gene associated with pancreatic cancer risk
Bensong Duan, Jiangfeng Hu, Hongliang Liu, Yanru Wang, Hongyu Li, Shun Liu, Jichun Xie, Kouros Owzar, James L. Abbruzzese, Herbert I. Hurwitz et al. · 2017 · International Journal of Cancer
Inhibition of CREPT restrains gastric cancer growth by regulation of cycle arrest, migration and apoptosis via ROS-regulated p53 pathway
Miao Sun, Gao Si, Hai-Shen Sun, Fu-Chun Si · 2018 · Biochemical and Biophysical Research Communications
Early-Stage Metastasis Requires Mdm2 and Not p53 Gain of Function
Paula M. Hauck, Eric R. Wolf, David J. Olivos, Christopher N. Batuello, Kyle C. McElyea, Ciarán P. McAtarsney, R. Michael Cournoyer, George Earl Sandusky, Lindsey D. Mayo · 2017 · Molecular Cancer Research
Mutant p53 regulates Survivin to foster lung metastasis
Qiaosi Tang, Gizem Efe, Anna M. Chiarella, Jessica C. Leung, Maoting Chen, Taiji Yamazoe, Zhenyi Su, Jason Robert Pitarresi, Jinyang Li, Mirazul Islam et al. · 2021 · Genes & Development
For robust big data analyses: a collection of 150 important pro-metastatic genes
Yan Mei, Jun-Ping Yang, Chao-Nan Qian · 2017 · 癌症：英文版
Multimodal Therapies against Pancreatic Ductal Adenocarcinoma: A Review on Synergistic Approaches toward Ultimate Nanomedicine Treatments
Marzia Conte, Valentina Cauda · 2022 · Advanced Therapeutics
Pancreatic cancer‐derived small extracellular vesical ezrin activates fibroblasts to exacerbate cancer metastasis through STAT3 and YAP ‐1 signaling pathways
Yu‐Ting Chang, Hsuan‐Yu Peng, Chun‐Mei Hu, Sui-Chih Tien, Yi‐Ing Chen, Yung‐Ming Jeng, Ming‐Chu Chang · 2023 · Molecular Oncology
Gain-of-function mutant p53 together with ERG proto-oncogene drive prostate cancer by beta-catenin activation and pyrimidine synthesis
Donglin Ding, Alexandra M. Blee, Jianong Zhang, Yunqian Pan, Nicole A. Becker, Louis James Maher, Rafael E. Jiménez, Liguo Wang, Haojie Huang · 2023 · Nature Communications
Mechanism of apoptosis activation by Curcumin rescued mutant p53Y220C in human pancreatic cancer
Lakshay Malhotra, Saurabh Sharma, Gururao Hariprasad, Renu Dhingra, Vandana Mishra, Radhey Shyam Sharma, Punit Kaur, Abdul Samath Ethayathulla · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Chromatin accessibility uncovers KRAS-driven FOSL2 promoting pancreatic ductal adenocarcinoma progression through up-regulation of CCL28
Shujun Zhang, Peilong Li, Juan Li, Jie Gao, Qiuchen Qi, Guoying Dong, Xiaoyan Liu, Qinlian Jiao, Yunshan Wang, Lutao Du et al. · 2023 · British Journal of Cancer
An unexpected inhibition of antiviral signaling by virus-encoded tumor suppressor p53 in pancreatic cancer cells
Eric L. Hastie, Marcela P. Cataldi, Nury Steuerwald, Valery Z. Grdzelishvili · 2015 · Virology
The Proprotein Convertase Furin Contributes to Rhabdomyosarcoma Malignancy by Promoting Vascularization, Migration and Invasion
Patricia Jaaks, Valentina D’Alessandro, Nicole Grob, Sina Büel, Katarina Hajdin, Beat W. Schäfer, Michele Bernasconi · 2016 · PLoS ONE
Human pancreatic cancer progression: an anarchy among CCN-siblings
Sushanta K. Banerjee, Gargi Maity, Inamul Haque, Arnab Ghosh, Sandipto Sarkar, Vijayalaxmi G. Gupta, Donald R. Campbell, Daniel D. Von Hoff, Snigdha Banerjee · 2016 · Journal of Cell Communication and Signaling
Generation of a pancreatic cancer model using a Pdx1-Flp recombinase knock-in allele
Jinghai Wu, Xin Liu, Sunayana G. Nayak, Jason Robert Pitarresi, Maria C. Cuitiño, Lianbo Yu, Blake Eason Hildreth, Katie Thies, Daniel J. Schilling, Soledad Fernández et al. · 2017 · PLoS ONE
Targeting of promising transmembrane proteins for diagnosis and treatment of pancreatic ductal adenocarcinoma
Vida Mashayekhi, Orsola Mocellin, Marcel H.A.M. Fens, Gerard C. Krijger, Lodewijk A.A. Brosens, Sabrina Oliveira · 2021 · Theranostics
Mutant p53-ENTPD5 control of the calnexin/calreticulin cycle: a druggable target for inhibiting integrin-α5-driven metastasis
Evangelos Pavlakis, Michelle M. Neumann, Nastasja Merle, Ronja Wieboldt, Michael Wanzel, Viviane Ponath, Elke Pogge von Strandmann, Sabrina Elmshäuser, Thorsten Stiewe · 2023 · Journal of Experimental & Clinical Cancer Research
Alpha-1-acid glycoprotein 1 is upregulated in pancreatic ductal adenocarcinoma and confers a poor prognosis
Qimin Zhou, Roland E. Andersson, Dingyuan Hu, Monika Posaric Bauden, Agata Sasor, Thomas Bygott, Krzysztof Pawłowski, Indira Plá, György Marko‐Varga, Daniel Ansari · 2019 · Translational research
Protein Advanced Glycation End Products and Their Implications in Pancreatic Cancer
Lakmini Kumari Senavirathna, Sheng Pan, Ru Chen · 2023 · Cancer Prevention Research
Epigenetic control of pancreatic cancer metastasis
Lukas Krauß, Carolin Schneider, Elisabeth Heßmann, Dieter Saur, Günter Schneider · 2023 · Cancer and Metastasis Reviews
Advances in understanding the molecular mechanism of pancreatic cancer metastasis
Yongxing Du, Ziwen Liu, Lei You, Wenming Wu, Yu-Pei Zhao · 2016 · Hepatobiliary & pancreatic diseases international
Discovering key transcriptomic regulators in pancreatic ductal adenocarcinoma using Dirichlet process Gaussian mixture model
Sk Md Mosaddek Hossain, Aanzil Akram Halsana, Lutfunnesa Khatun, Sumanta Ray, Anirban Mukhopadhyay · 2021 · Scientific Reports
microRNAs: short non-coding bullets of gain of function mutant p53 proteins
Sara Donzelli, Sabrina Strano, Giovanni Blandino · 2014 · Oncoscience
Valosin-Containing Protein Stabilizes Mutant p53 to Promote Pancreatic Cancer Growth
Jieqiong Wang, Yajie Chen, Canhua Huang, Qian Hao, Shelya X. Zeng, Sara Omari, Yu Zhang, Xiang Yu Zhou, Hua Lu · 2021 · Cancer Research
TGFβ Drives Metabolic Perturbations during Epithelial Mesenchymal Transition in Pancreatic Cancer: TGFβ Induced EMT in PDAC
Meena U. Rajagopal, Shivani Bansal, Prabhjit Kaur, Shreyans Kumar Jain, Tatiana Altadill, Charles P. Hinzman, Yaoxiang Li, Joanna Moulton, Baldev B. Singh, Sunil Bansal et al. · 2021 · Cancers
From regulation to deregulation of p53 in hematologic malignancies: implications for diagnosis, prognosis and therapy
Seyed Esmaeil Ahmadi, Elahe Rahimian, Samira Rahimi, Bahman Zarandi, Mehran Bahraini, Maral Soleymani, Seyed Mehrab Safdari, Ashkan Shabannezhad, Niloofar Jaafari, Majid Safa · 2024 · Biomarker Research
Adrenomedullin promotes the growth of pancreatic ductal adenocarcinoma through recruitment of myelomonocytic cells
Min Xu, Feifei Qi, Shaosen Zhang, Xuhui Ma, Shan Wang, Chunying Wang, Yan Fu, Yongzhang Luo · 2016 · Oncotarget
Control of Nucleotide Metabolism Enables Mutant p53’s Oncogenic Gain-of-Function Activity
Valentina A. Schmidt, Rachana Nagar, Luis A. Martinez · 2017 · International Journal of Molecular Sciences
p53 mutations define the chromatin landscape to confer drug tolerance in pancreatic cancer
Carlotta Zampieri, Emanuele Panatta, Vincenzo Corbo, Alessandro Mauriello, Gerry Melino, Ivano Amelio · 2021 · Molecular Oncology
Immunotherapy in hepatocellular carcinoma: an overview of immune checkpoint inhibitors, drug resistance, and adverse effects
Xuan-Yu Gu, Jin-Long Huo, Zhiyong Yu, Ji-Chang Jiang, Ya-Xuan Xu, Lijin Zhao · 2024 · ONCOLOGIE
ErbB2 inhibition by lapatinib promotes degradation of mutant p53 protein in cancer cells
Dun Li, Natalia D. Marchenko · 2016 · Oncotarget
Molecular Guided Therapy Provides Sustained Clinical Response in Refractory Choroid Plexus Carcinoma
Albert S. Cornelius, Jessica M. Foley, Jeffrey P. Bond, Abhinav Beeravally Nagulapally, Julie Steinbrecher, William P.D. Hendricks, Maria E. Rich, Sangeeta Yendrembam, Genevieve Bergendahl, Jeffrey M. Trent et al. · 2017 · Frontiers in Pharmacology
Diverse and cancer type‑specific roles of the p53 R248Q gain‑of‑function mutation in cancer migration and invasiveness
Maciej B. Olszewski, Magdalena Pruszko, Ewa B. Snaar-Jagalska, Maciej Żylicz, Maciej Żylicz · 2019 · International Journal of Oncology
Beyond the Mevalonate Pathway: Control of Post-Prenylation Processing by Mutant p53
Carla M. Borini Etichetti, Evelyn Arel Zalazar, Nabila Cocordano, Javier E. Girardini · 2020 · Frontiers in Oncology
Chaperones and Ubiquitin Ligases Balance Mutant p53 Protein Stability in Esophageal and Other Digestive Cancers
May San Martinho, Derek J. Nancarrow, Theodore Steven Lawrence, David G. Beer, Dipankar Ray · 2020 · Cellular and Molecular Gastroenterology and Hepatology
Clinical Applications of Classical and Novel Biological Markers of Pancreatic Cancer
Leonel Pekarek, Oscar Fraile‐Μartinez, Cielo García Montero, Miguel A. Sáez, Ines Barquero-Pozanco, Laura del Hierro-Marlasca, Patricia De Castro-Martinez, Adoración Romero-Bazán, Miguel Ángel Álvarez-Mon, Jorge Monserrat et al. · 2022 · Cancers
Ganetespib synergizes with cyclophosphamide to improve survival of mice with autochthonous tumors in a mutant p53-dependent manner
Evguenia M. Alexandrova, Sulan Xu, Ute Martha Moll · 2017 · Cell Death and Disease
Hallmarks of liver cancer: Therapeutic implications
Josep Maria Llovet, Roser Pinyol, Silvia Affò, Mark M. Yarchoan, Gregory James Gores, Robin Kate Kelley, Scott W. Lowe, Daniela Sia, Augusto Villanueva · 2026 · Cell
Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53
Stephen Lee Abrams, Przemysław Duda, Shaw M. Akula, Linda S. Steelman, Matilde L. Follo, Lucio Cocco, Stefano Ratti, Alberto Maria Martelli, Giuseppe Montalto, Maria Rita Emma et al. · 2022 · Cells
Role of Epigenetics in Pancreatic Ductal Adenocarcinoma
Somnath Pandey, Vineet Kumar Gupta, Shweta Lavania · 2023 · Epigenomics
The high expression instead of mutation of p53 is predictive of overall survival in patients with esophageal squamous‐cell carcinoma: a meta‐analysis
Ziran Zhao, Pan Wang, Yibo Gao, Jie He · 2016 · Cancer Medicine
Mutant TP53 modulates metastasis of triple negative breast cancer through adenosine A2b receptor signaling
Eisuke Horigome, Michiru Fujieda, Tadashi Handa, Ayaka Katayama, Masashi Ito, Ami Ichihara, Daiki Tanaka, Navchaa Gombodorj, Shinji Yoshiyama, Arito Yamane et al. · 2018 · Oncotarget
The Diverse Functions of Mutant 53, Its Family Members and Isoforms in Cancer
Callum Hall, Patricia A. J. Muller · 2019 · International Journal of Molecular Sciences
Differentiating TP53 Mutation Status in Pancreatic Ductal Adenocarcinoma Using Multiparametric MRI-Derived Radiomics
Jing Gao, Xiahan Chen, Xudong Li, Fei Miao, Weihuan Fang, Biao Li, Xiaohua Qian, Xiaozhu Lin · 2021 · Frontiers in Oncology
A Novel Biomarker Panel Examining Response to Gemcitabine with or without Erlotinib for Pancreatic Cancer Therapy in NCIC Clinical Trials Group PA.3
David Benjamin Shultz, Jonathan Pai, Wayland Chiu, Kendall Ng, Madeline G. Hellendag, Gregory M. Heestand, Daniel Tandel Chang, Dongsheng Tu, Malcolm J. Moore, Wendy R. Parulekar et al. · 2016 · PLoS ONE
Decreased mean platelet volume predicts poor prognosis in patients with pancreatic cancer
Takuki Yagyu, Hiroaki Saito, Teruhisa Sakamoto, Ei Uchinaka, Masaki Morimoto, Takehiko Hanaki, Joji Watanabe, Tomoyuki Matsunaga, Manabu Yamamoto, Naruo Tokuyasu et al. · 2021 · BMC Surgery
The Multifaceted Role of p53 in Cancer Molecular Biology: Insights for Precision Diagnosis and Therapeutic Breakthroughs
Bolong Xu, Ayitila Maimaitijiang, Dawuti Nuerbiyamu, Zhengding Su, Wenfang Li · 2025 · Biomolecules
PAI1 is a Marker of Bad Prognosis in Rectal Cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208
Sandra Muñoz-Galván, Maria Rivero, J. Peinado, Julia Martínez‐Pérez, MC Fernández-Fernández, María José Ortiz, José Manuel García-Heredia, Amancio Carnero · 2020 · Cells
Commensal microbes and p53 in cancer progression
Ivana Celardo, Gerry Melino, Ivano Amelio · 2020 · Biology Direct
Bayesian Pathway Analysis of Cancer Microarray Data
Melike Korucuoglu, Senol Isci, Arzucan Özgür, Hasan H. Otu · 2014 · PLoS ONE
Gene Regulation by p53 in Human Cancer System
Supratit Ghosh, Meghna Bhattacharjee, Nandan Kumar Jana · 2022 · Asian Pacific Journal of Cancer Biology
TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma
Haiwei Wang, Xinrui Wang, Liangpu Xu, Ji Zhang · 2022 · BMC Genomic Data
Identification of genes and pathways associated with pancreatic ductal adenocarcinoma by bioinformatics analyses
Jin Long, Zhongbo Zhang, Zhe Liu, Yuanhong Xu, Chunlin Ge · 2015 · Oncology Letters
Integrative landscape of dysregulated signaling pathways of clinically distinct pancreatic cancer subtypes
Musalula Sinkala, Nicola Mulder, Darren Patrick Martin · 2018 · Oncotarget
p53 gain-of-function mutations promote metastasis via ENTPD5 upregulation and enhanced N-glycoprotein folding
Oleg N. Timofeev, Thorsten Stiewe · 2017 · Molecular & Cellular Oncology
Molecular Research in Pancreatic Cancer: Small Molecule Inhibitors, Their Mechanistic Pathways and Beyond
Shaila A. Shetu, Nneoma James, Gildardo Rivera, Debasish Bandyopadhyay · 2023 · Current Issues in Molecular Biology
Inhibiting CDK4/6 in pancreatic ductal adenocarcinoma via microRNA-21
Maria Mortoglou, Francesc Miralles, Rhys Richard Mould, Dipankar Sengupta, Pinar Uysal Onganer · 2023 · European Journal of Cell Biology